India's Growing Appetite for Weight Loss Drugs: A Double-Edged Sword
The Indian market is witnessing a surge in the popularity of weight loss drugs, particularly Mounjaro, which has become one of the top-selling medications in the country. This trend is fueled by the recent expiration of a key patent on semaglutide, the active ingredient in drugs like Ozempic and Wegovy, allowing Indian pharmaceutical companies to launch lower-cost generic versions. While this development has made weight loss treatments more affordable, it has also raised concerns among healthcare professionals about the potential misuse and side effects of these drugs.
One of the primary reasons for the increased demand is the high prevalence of overweight adults and Type 2 diabetes in India. According to The Lancet medical journal, the country has the second-highest number of overweight adults and over 77 million people with Type 2 diabetes. This has led to a growing awareness of obesity and a willingness among individuals to seek medical intervention.
However, the accessibility of cheaper generic drugs has also led to a surge in their use, even among those who are not considered obese. Doctor Preethi Mrinalini, a laparoscopic and bariatric surgeon in Chennai, has noticed a trend where people are more readily prescribing weight loss drugs without considering their eligibility. This raises concerns about the potential misuse and side effects of these medications.
The side effects of Mounjaro, in particular, can be severe and include nausea, vomiting, diarrhea, and constipation. More serious side effects, such as pancreatitis, severe dehydration, hyperglycemia, and gallbladder issues, are also possible. This has led to calls for mandatory registration of patients on these medications with a monitoring system and clear digital prescription trails to ensure proper medical supervision and prevent misuse.
The issue of misuse is further complicated by the availability of these drugs through multiple channels, including social media. Jennifer Joseph, a digital content creator, shared her experience of taking Mounjaro, which helped her lose six kilograms in the first month. However, she also noted the importance of awareness, structure, and medical support when using these powerful tools. Without proper guidance, it's easy to misunderstand or misuse them, leading to potential health risks.
The growing demand for weight loss drugs in India has also sparked a debate about the role of social media in promoting their use. Amita Gadre, a nutritionist in Pune, expressed concern about the potential for misuse aided by the availability of generic drugs. She called for mandatory registration of patients, clear digital prescription trails, and standardized patient counseling requirements to ensure safe and effective use of these medications.
In conclusion, while the availability of cheaper weight loss drugs in India has made them more accessible, it has also raised concerns about misuse and side effects. Healthcare professionals are calling for stricter regulations and monitoring systems to ensure that these medications are used safely and effectively. As the market for weight loss drugs continues to grow, it is crucial to strike a balance between accessibility and safety to prevent potential harm to patients.
